The Blood Grouping Reagents Market in Brazil has experienced a general downward trend from 2012 to 2022, with the market size decreasing from $46.381 million to $38.274 million. This represents an overall decline amidst fluctuating year-on-year variations. Specifically, the market saw notable declines in 2013, 2014, 2018, 2019, 2020, and 2022 with a few brief periods of growth in 2016 and minor stability in 2015 and 2021.
Over the last two years, the market showed a slight upturn in 2021 with a positive year-on-year variation of 0.32% but dropped again by 1.38% in 2022. The compound annual growth rate (CAGR) over the last five years has been negative, reflecting a challenging market environment with a CAGR of -2.76% from 2017 to 2022.
For future trends, watch for:
- Technological advancements in blood grouping techniques.
- Increased demand due to rising healthcare awareness and diagnostic needs.
- Potential economic factors influencing healthcare expenditure and reagent purchasing power.
- Regulatory changes impacting the production and sale of blood grouping reagents.
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | |
| 6 | 6 Poland | 22,266,000 | 2023 | +0.22% | +0.62% | View data |
| 7 | 7 Thailand | 20,590,000 | 2023 | +5.58% | +6.99% | View data |
